Skip to content
PubMed This is a summary of 15 peer-reviewed journal articles Updated
Endocrinology · Vasoactive Intestinal Peptide–Secreting Tumor

The Biology of VIPoma and Why It Is Misdiagnosed

At a Glance

VIPoma is a rare hormone-producing tumor, usually found in the pancreas, that releases excess VIP and causes high-volume secretory diarrhea that can continue during fasting or overnight. Because it can resemble IBS or infection, diagnosis may be delayed until targeted VIP testing is performed.

Understanding why your body is reacting this way requires looking at a single hormone: Vasoactive Intestinal Peptide (VIP). While your body needs a small amount of VIP to function, a VIPoma acts like a broken faucet, flooding your system with this hormone and triggering a cascade of digestive chaos [1][2].

The Normal Role of VIP

In a healthy person, VIP is a “messenger” hormone that helps coordinate how your gut moves and processes food [3]. Its normal jobs include:

  • Relaxing muscles: It helps the smooth muscles of the stomach and intestines relax so food can pass through [4].
  • Controlling blood flow: It widens blood vessels (vasodilation) in the gut to help with nutrient absorption [1].
  • Regulating fluids: It signals the intestines to release small amounts of water and salts (electrolytes) to keep digestion moving smoothly [5].

When a VIPoma tumor develops, it releases VIP at levels hundreds of times higher than normal [6]. This forces your intestines into “overdrive,” pumping massive amounts of water and electrolytes out of your blood and into your stool [7].

Secretory vs. Osmotic Diarrhea

One of the most important clues in diagnosing a VIPoma is the type of diarrhea it causes. Some common digestive issues cause osmotic diarrhea, but VIPoma causes secretory diarrhea [7].

Feature Osmotic Diarrhea (e.g., Food Intolerance) Secretory Diarrhea (e.g., VIPoma)
Reaction to Fasting Diarrhea usually stops or improves when you stop eating [8]. Diarrhea continues at high volumes even if you do not eat [9]. (Note: Do not fast deliberately unless instructed by your clinical team).
Overnight Symptoms Rarely wakes you up at night. Often occurs overnight, regardless of food intake [9].
Cause Unabsorbed food “pulls” water into the gut [7]. The gut actively “pumps” water and salts out into the stool [7].
Volume Typically moderate. Can be massive (liters per day) [6].

The Path to Diagnosis: Why It Takes Time

Because VIPoma is so rare—affecting only about 1 in 10 million people—doctors rarely suspect it at first [10]. It is common for patients to spend months or even years seeking an answer [11]. You may have been told you had one of the following before finding the truth:

  • Irritable Bowel Syndrome (IBS): This is a very common misdiagnosis. However, unlike IBS, VIPoma causes significant weight loss, severe potassium depletion, and diarrhea that persists during sleep [9][6].
  • Laxative Abuse: Because the electrolyte imbalances look similar to those caused by overusing laxatives, some patients are wrongly suspected of “hiding” a laxative habit [12].
  • Chronic Infections: Doctors may test for parasites or rare bacteria repeatedly because the diarrhea is so persistent [11].
  • Celiac Disease or Crohn’s: Inflammatory or malabsorption issues are often ruled out through colonoscopies and biopsies before a doctor looks at the pancreas [11].

If your diagnosis was delayed, it was not because your symptoms weren’t real; it was because VIPoma is a “needle in a haystack” condition that requires specific hormonal testing to find [9].

Subtypes: Sporadic vs. MEN1

Not all VIPomas are the same. They generally fall into two categories:

1. Sporadic VIPoma
Most VIPomas occur “out of the blue” with no known genetic cause (estimates vary, but often cited around 95%) [10]. These are frequently solitary tumors, often located in the tail of the pancreas, though they can occur elsewhere [13].

2. MEN1-Associated VIPoma
A small number of VIPomas are part of a genetic condition called Multiple Endocrine Neoplasia type 1 (MEN1) [10]. If you have the MEN1 subtype:

  • The tumors may be multifocal, meaning there are several small tumors in the pancreas rather than just one [14].
  • You may develop other endocrine issues, such as overactive parathyroid glands (leading to high calcium) or pituitary tumors [15][2].
  • This subtype often appears at a younger age than sporadic cases [2].

Your doctor may recommend a consultation with a genetics professional if they suspect your VIPoma is linked to MEN1 based on age, family history, or other clinical findings [14].

Common questions in this guide

What kind of diarrhea does a VIPoma cause?
A VIPoma typically causes secretory diarrhea, meaning the intestine actively releases large amounts of water and electrolytes into the stool. It can be very watery and high-volume, continue even when a person is not eating, and occur overnight.
Why is VIPoma often mistaken for IBS or an infection?
VIPoma is extremely rare, while IBS and infections are much more common explanations for ongoing diarrhea. Persistent high-volume diarrhea, weight loss, severe potassium loss, and symptoms that continue during sleep may point to VIPoma and require targeted VIP testing.
How does the stool osmotic gap help diagnose VIPoma?
The stool osmotic gap helps clinicians distinguish diarrhea caused by active intestinal secretion from diarrhea caused by unabsorbed food or other substances drawing water into the gut. A pattern consistent with secretory diarrhea supports further evaluation for causes such as VIPoma, but it does not diagnose the tumor by itself.
Could a VIPoma be related to MEN1?
Yes. A small proportion of VIPomas occur with multiple endocrine neoplasia type 1, an inherited condition that can also affect the parathyroid glands and pituitary. Multifocal pancreatic tumors, younger age, high calcium, or a family history may lead a clinician to recommend genetic counseling or testing.
How is VIPoma evaluated after a delayed diagnosis?
After evaluating the pattern of ongoing high-volume secretory diarrhea, clinicians may measure blood VIP and exclude other causes. The blood sample needs careful handling, such as prompt chilling and processing, because collection conditions can affect the result.

Get notified when new evidence is published on pancreatic vasoactive intestinal peptide producing tumor.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (15)
  1. 1

    Vasoactive intestinal peptide promotes secretory differentiation and mitigates radiation-induced intestinal injury.

    Agibalova T, Hempel A, Maurer HC, et al.

    Stem cell research & therapy 2024; (15(1)):348 doi:10.1186/s13287-024-03958-z.

    PMID: 39380035
  2. 2

    Perioperative Hypotensive Crisis in an Adolescent with a Pancreatic VIPoma and MEN1-Gene Variant.

    Acosta-Gualandri A, Kao KT, Wong T, et al.

    Hormone research in paediatrics 2019; (91(4)):285-289 doi:10.1159/000493396.

    PMID: 30326482
  3. 3

    Chemically induced inflammation and nerve damage affect the distribution of vasoactive intestinal polypeptide-like immunoreactive (VIP-LI) nervous structures in the descending colon of the domestic pig.

    Makowska K

    Neurogastroenterology and motility 2018; (30(11)):e13439 doi:10.1111/nmo.13439.

    PMID: 30109906
  4. 4

    Myogenic oxidative imbalance interferes with antral motility in obese subjects.

    Scirocco A, Pallotta L, Rengo M, et al.

    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2018; (50(8)):820-827 doi:10.1016/j.dld.2018.03.005.

    PMID: 29625905
  5. 5

    Recent advances in vasoactive intestinal peptide physiology and pathophysiology: focus on the gastrointestinal system.

    Iwasaki M, Akiba Y, Kaunitz JD

    F1000Research 2019; (8()) doi:10.12688/f1000research.18039.1.

    PMID: 31559013
  6. 6

    Chronic Diarrhea Secondary to Newly Diagnosed VIPoma.

    Farina DA, Krogh KM, Boike JR

    Case reports in gastroenterology 2019; (13(1)):225-229 doi:10.1159/000494554.

    PMID: 31123451
  7. 7

    Congenital disorders of intestinal digestion and absorption (sugars, proteins, lipids, ions).

    Peretti N, Mas E

    Best practice & research. Clinical gastroenterology 2022; (56-57()):101785 doi:10.1016/j.bpg.2022.101785.

    PMID: 35331397
  8. 8

    Chronic Diarrhea in Adults: Evaluation and Differential Diagnosis.

    Burgers K, Lindberg B, Bevis ZJ

    American family physician 2020; (101(8)):472-480.

    PMID: 32293842
  9. 9

    Severe Idiopathic Secretory Diarrhoea With a Profound Sustained Response to Somatostatin Analogues: A Case Report.

    Gandy G, Prudence AJA, Levy MT

    Case reports in gastrointestinal medicine 2025; (2025()):7006260 doi:10.1155/crgm/7006260.

    PMID: 41195063
  10. 10

    Vasoactive intestinal peptide secreting tumour: An overview.

    Una Cidon E

    World journal of gastrointestinal oncology 2022; (14(4)):808-819 doi:10.4251/wjgo.v14.i4.808.

    PMID: 35582098
  11. 11

    Severe hypokalaemia and secretory diarrhoea secondary to a vasoactive intestinal peptide-secreting tumour (VIPoma).

    Stafl L, Ruzycki S, Kline G, Lithgow K

    BMJ case reports 2026; (19(7)) doi:10.1136/bcr-2026-274867.

    PMID: 42409425
  12. 12

    Surgical resection of vasoactive intestinal peptideoma with hepatic metastasis aids symptom palliation: A case report.

    Zhang X, Zhou L, Liu Y, et al.

    Experimental and therapeutic medicine 2016; (11(3)):783-787 doi:10.3892/etm.2016.3019.

    PMID: 26997993
  13. 13

    Clinicopathological data and treatment modalities for pancreatic vipomas: a systematic review.

    Schizas D, Mastoraki A, Bagias G, et al.

    Journal of B.U.ON. : official journal of the Balkan Union of Oncology 2019; (24(2)):415-423.

    PMID: 31127985
  14. 14

    VIPoma with multiple endocrine neoplasia type 1 identified as an atypical gene mutation.

    Fujiya A, Kato M, Shibata T, Sobajima H

    BMJ case reports 2015; (2015()).

    PMID: 26564120
  15. 15

    How Disease Progression Changes Operative Thresholds in MEN1: A Case-Based Management Review.

    Jomy A, Logarajah S, Abraham A, et al.

    The American surgeon 2026; 31348261480819 doi:10.1177/00031348261480819.

    PMID: 42634439

This page explains VIPoma biology and possible diagnostic delays for informational purposes only and does not constitute medical advice. Your endocrinology or gastroenterology team should interpret your symptoms, test results, and MEN1 risk.